InClinica

Wayne, United States Founded: 2016 • Age: 10 yrs Acquired By Velocity Fund Partners
Clinical CRO specializing in first in man and phase 2 studies.

About InClinica

InClinica is a company based in Wayne (United States) founded in 2016 was acquired by Velocity Fund Partners in June 2016.. InClinica has raised $375 thousand across 1 funding round from investors including Velocity Fund Partners. InClinica operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.

  • Headquarter Wayne, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $375 K (USD)

    in 1 rounds

  • Latest Funding Round
    $375 K (USD), Seed

    Sep 24, 2018

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of InClinica

InClinica has successfully raised a total of $375K through 1 strategic funding round. The most recent funding activity was a Seed round of $375 thousand completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $374,999
  • First Round

    (24 Sep 2018)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2018 Amount Seed - InClinica Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in InClinica

InClinica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Velocity Fund Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are directed toward USA-based companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by InClinica

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - InClinica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Inclinica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of InClinica

InClinica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
Full-service clinical research organization services are provided globally by Parexel.
domain founded_year HQ Location
Global full-service CRO services are delivered in over 80 countries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Inclinica

InClinica Appoints Senior Director of QA
Contractpharma7 years ago
InClinica Names BD Manager
Contractpharma7 years ago

Frequently Asked Questions about InClinica

When was InClinica founded?

InClinica was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is InClinica located?

InClinica is headquartered in Wayne, United States.

Is InClinica a funded company?

InClinica is a funded company, having raised a total of $375K across 1 funding round to date. The company's 1st funding round was a Seed of $375K, raised on Sep 24, 2018.

What does InClinica do?

InClinica is a global clinical contract research organization founded (relaunched) in 2016 after the acquisition of Indipharm Clinical Research by Velocity Fund Partners, a private equity firm that targets life science product development and healthcare services. It works across all phases of clinical development, with expertise in assisting small to mid-sized companies entering first in man and phase 2 studies. The company claims to have more than 100 combined years of clinical research experience in multiple diseases and device technology. They specifically focus in oncology, dermatology, metabolic disease and inflammatory diseases. They also claim to have deep experience in diseases as diverse as cardiovascular disease, GI disorders and infectious disease. They also have experience in conducting trials across all stages of clinical trials, in North America, AsiaPacific, Europe and Latin America. Their services include clinical trial initiation, performing onsite monitoring, pre-study and site initiation, routine monitoring and close-out visits, as well as preparation of monitoring plans and supervision of clinical research associates (CRAs). They also have capabilities for managing global budgets for studies and vendors and managing third party vendors.

Who are the top competitors of InClinica?

InClinica's top competitors include Emmes, Syneos Health and ClinChoice.

Who are InClinica's investors?

InClinica has 1 investor. Key investors include Velocity Fund Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available